Pattern ERGs suggest a possible retinal contribution to the visual acuity loss in acute optic neuritis
Purpose Macular involvement in optic neuritis (ON) is well-recognised but poorly understood and may be of clinical relevance. This study explores macular structure–function correlates in acute ON. Methods This cross-sectional cohort study recruited ON patients within 14 days of symptom onset. Subjec...
Saved in:
| Published in | Documenta ophthalmologica Vol. 145; no. 3; pp. 185 - 195 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.12.2022
Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0012-4486 1573-2622 1573-2622 |
| DOI | 10.1007/s10633-022-09896-6 |
Cover
| Abstract | Purpose
Macular involvement in optic neuritis (ON) is well-recognised but poorly understood and may be of clinical relevance. This study explores macular structure–function correlates in acute ON.
Methods
This cross-sectional cohort study recruited ON patients within 14 days of symptom onset. Subjects underwent pattern electroretinography (PERG), pattern visual evoked potentials (PVEP) and optical coherence tomography (OCT) imaging. PERG P50 and N95 components were correlated with OCT data.
Results
Twenty-six individuals with ON were recruited, comprising eleven multiple sclerosis (MS-ON), six myelin oligodendrocyte glycoprotein associated (MOG-ON) and nine with isolated ON. These were compared with 28 healthy controls. PVEPs were undetectable in 11 (42%) of individuals with ON. When detectable, PVEP P100 was delayed (median 136 ms range 110–173 ms) and amplitude reduced (median 6 μV, range 3–14 μV) in ON compared with controls (both
p
< 0.001). PERG P50 component amplitudes, largely reflecting macular function, were reduced in affected eyes (median 2.3 μV; range 0.8–5.0 μV) compared with controls (3.3 μV; range 2.8–5.7 μV) and compared with fellow eyes (
p
< 0.001). The N95:P50 ratio was below the reference range in the affected eyes of five patients. Eight cases (32%) had subnormal P50 amplitudes (< 2.0 μV), and these patients had poorer visual acuity (
p
= 0.020). P50 amplitudes were positively correlated with an increase in inner nuclear layer thickness (
r
s
= 0.36;
p
= 0.009) and macular ganglion cell and inner plexiform layer (mGCIPL) thickness (
r
s
= 0.44,
p
= 0.022).
Conclusion
PERG P50 component reduction reveals dysfunction of inner macular layers in acute ON and correlates with structural alterations on OCT. These early macular pathologic processes are likely to contribute to the visual loss. |
|---|---|
| AbstractList | PurposeMacular involvement in optic neuritis (ON) is well-recognised but poorly understood and may be of clinical relevance. This study explores macular structure–function correlates in acute ON.MethodsThis cross-sectional cohort study recruited ON patients within 14 days of symptom onset. Subjects underwent pattern electroretinography (PERG), pattern visual evoked potentials (PVEP) and optical coherence tomography (OCT) imaging. PERG P50 and N95 components were correlated with OCT data.ResultsTwenty-six individuals with ON were recruited, comprising eleven multiple sclerosis (MS-ON), six myelin oligodendrocyte glycoprotein associated (MOG-ON) and nine with isolated ON. These were compared with 28 healthy controls. PVEPs were undetectable in 11 (42%) of individuals with ON. When detectable, PVEP P100 was delayed (median 136 ms range 110–173 ms) and amplitude reduced (median 6 μV, range 3–14 μV) in ON compared with controls (both p < 0.001). PERG P50 component amplitudes, largely reflecting macular function, were reduced in affected eyes (median 2.3 μV; range 0.8–5.0 μV) compared with controls (3.3 μV; range 2.8–5.7 μV) and compared with fellow eyes (p < 0.001). The N95:P50 ratio was below the reference range in the affected eyes of five patients. Eight cases (32%) had subnormal P50 amplitudes (< 2.0 μV), and these patients had poorer visual acuity (p = 0.020). P50 amplitudes were positively correlated with an increase in inner nuclear layer thickness (rs = 0.36; p = 0.009) and macular ganglion cell and inner plexiform layer (mGCIPL) thickness (rs = 0.44, p = 0.022).ConclusionPERG P50 component reduction reveals dysfunction of inner macular layers in acute ON and correlates with structural alterations on OCT. These early macular pathologic processes are likely to contribute to the visual loss. Macular involvement in optic neuritis (ON) is well-recognised but poorly understood and may be of clinical relevance. This study explores macular structure-function correlates in acute ON.PURPOSEMacular involvement in optic neuritis (ON) is well-recognised but poorly understood and may be of clinical relevance. This study explores macular structure-function correlates in acute ON.This cross-sectional cohort study recruited ON patients within 14 days of symptom onset. Subjects underwent pattern electroretinography (PERG), pattern visual evoked potentials (PVEP) and optical coherence tomography (OCT) imaging. PERG P50 and N95 components were correlated with OCT data.METHODSThis cross-sectional cohort study recruited ON patients within 14 days of symptom onset. Subjects underwent pattern electroretinography (PERG), pattern visual evoked potentials (PVEP) and optical coherence tomography (OCT) imaging. PERG P50 and N95 components were correlated with OCT data.Twenty-six individuals with ON were recruited, comprising eleven multiple sclerosis (MS-ON), six myelin oligodendrocyte glycoprotein associated (MOG-ON) and nine with isolated ON. These were compared with 28 healthy controls. PVEPs were undetectable in 11 (42%) of individuals with ON. When detectable, PVEP P100 was delayed (median 136 ms range 110-173 ms) and amplitude reduced (median 6 μV, range 3-14 μV) in ON compared with controls (both p < 0.001). PERG P50 component amplitudes, largely reflecting macular function, were reduced in affected eyes (median 2.3 μV; range 0.8-5.0 μV) compared with controls (3.3 μV; range 2.8-5.7 μV) and compared with fellow eyes (p < 0.001). The N95:P50 ratio was below the reference range in the affected eyes of five patients. Eight cases (32%) had subnormal P50 amplitudes (< 2.0 μV), and these patients had poorer visual acuity (p = 0.020). P50 amplitudes were positively correlated with an increase in inner nuclear layer thickness (rs = 0.36; p = 0.009) and macular ganglion cell and inner plexiform layer (mGCIPL) thickness (rs = 0.44, p = 0.022).RESULTSTwenty-six individuals with ON were recruited, comprising eleven multiple sclerosis (MS-ON), six myelin oligodendrocyte glycoprotein associated (MOG-ON) and nine with isolated ON. These were compared with 28 healthy controls. PVEPs were undetectable in 11 (42%) of individuals with ON. When detectable, PVEP P100 was delayed (median 136 ms range 110-173 ms) and amplitude reduced (median 6 μV, range 3-14 μV) in ON compared with controls (both p < 0.001). PERG P50 component amplitudes, largely reflecting macular function, were reduced in affected eyes (median 2.3 μV; range 0.8-5.0 μV) compared with controls (3.3 μV; range 2.8-5.7 μV) and compared with fellow eyes (p < 0.001). The N95:P50 ratio was below the reference range in the affected eyes of five patients. Eight cases (32%) had subnormal P50 amplitudes (< 2.0 μV), and these patients had poorer visual acuity (p = 0.020). P50 amplitudes were positively correlated with an increase in inner nuclear layer thickness (rs = 0.36; p = 0.009) and macular ganglion cell and inner plexiform layer (mGCIPL) thickness (rs = 0.44, p = 0.022).PERG P50 component reduction reveals dysfunction of inner macular layers in acute ON and correlates with structural alterations on OCT. These early macular pathologic processes are likely to contribute to the visual loss.CONCLUSIONPERG P50 component reduction reveals dysfunction of inner macular layers in acute ON and correlates with structural alterations on OCT. These early macular pathologic processes are likely to contribute to the visual loss. Macular involvement in optic neuritis (ON) is well-recognised but poorly understood and may be of clinical relevance. This study explores macular structure-function correlates in acute ON. This cross-sectional cohort study recruited ON patients within 14 days of symptom onset. Subjects underwent pattern electroretinography (PERG), pattern visual evoked potentials (PVEP) and optical coherence tomography (OCT) imaging. PERG P50 and N95 components were correlated with OCT data. Twenty-six individuals with ON were recruited, comprising eleven multiple sclerosis (MS-ON), six myelin oligodendrocyte glycoprotein associated (MOG-ON) and nine with isolated ON. These were compared with 28 healthy controls. PVEPs were undetectable in 11 (42%) of individuals with ON. When detectable, PVEP P100 was delayed (median 136 ms range 110-173 ms) and amplitude reduced (median 6 μV, range 3-14 μV) in ON compared with controls (both p < 0.001). PERG P50 component amplitudes, largely reflecting macular function, were reduced in affected eyes (median 2.3 μV; range 0.8-5.0 μV) compared with controls (3.3 μV; range 2.8-5.7 μV) and compared with fellow eyes (p < 0.001). The N95:P50 ratio was below the reference range in the affected eyes of five patients. Eight cases (32%) had subnormal P50 amplitudes (< 2.0 μV), and these patients had poorer visual acuity (p = 0.020). P50 amplitudes were positively correlated with an increase in inner nuclear layer thickness (r = 0.36; p = 0.009) and macular ganglion cell and inner plexiform layer (mGCIPL) thickness (r = 0.44, p = 0.022). PERG P50 component reduction reveals dysfunction of inner macular layers in acute ON and correlates with structural alterations on OCT. These early macular pathologic processes are likely to contribute to the visual loss. Purpose Macular involvement in optic neuritis (ON) is well-recognised but poorly understood and may be of clinical relevance. This study explores macular structure–function correlates in acute ON. Methods This cross-sectional cohort study recruited ON patients within 14 days of symptom onset. Subjects underwent pattern electroretinography (PERG), pattern visual evoked potentials (PVEP) and optical coherence tomography (OCT) imaging. PERG P50 and N95 components were correlated with OCT data. Results Twenty-six individuals with ON were recruited, comprising eleven multiple sclerosis (MS-ON), six myelin oligodendrocyte glycoprotein associated (MOG-ON) and nine with isolated ON. These were compared with 28 healthy controls. PVEPs were undetectable in 11 (42%) of individuals with ON. When detectable, PVEP P100 was delayed (median 136 ms range 110–173 ms) and amplitude reduced (median 6 μV, range 3–14 μV) in ON compared with controls (both p < 0.001). PERG P50 component amplitudes, largely reflecting macular function, were reduced in affected eyes (median 2.3 μV; range 0.8–5.0 μV) compared with controls (3.3 μV; range 2.8–5.7 μV) and compared with fellow eyes ( p < 0.001). The N95:P50 ratio was below the reference range in the affected eyes of five patients. Eight cases (32%) had subnormal P50 amplitudes (< 2.0 μV), and these patients had poorer visual acuity ( p = 0.020). P50 amplitudes were positively correlated with an increase in inner nuclear layer thickness ( r s = 0.36; p = 0.009) and macular ganglion cell and inner plexiform layer (mGCIPL) thickness ( r s = 0.44, p = 0.022). Conclusion PERG P50 component reduction reveals dysfunction of inner macular layers in acute ON and correlates with structural alterations on OCT. These early macular pathologic processes are likely to contribute to the visual loss. |
| Author | Trip, S. A. Del Porto, L. Robson, A. G. Leo, S. Guajardo, J. Petzold, A. Plant, G. T. Kleerekooper, I. Dell’Arti, L. Holder, G. E. |
| Author_xml | – sequence: 1 givenname: I. orcidid: 0000-0001-6456-9034 surname: Kleerekooper fullname: Kleerekooper, I. email: Iris.kleerekooper.18@ucl.ac.uk organization: Moorfields Eye Hospital, Queen Square MS CentreDepartment of Neuroinflammation, UCL Institute of Neurology, Institute of Neurology, University College London, MS Centre – sequence: 2 givenname: L. surname: Del Porto fullname: Del Porto, L. organization: Moorfields Eye Hospital, The Royal Victorian Eye and Ear Hospital Melbourne – sequence: 3 givenname: L. surname: Dell’Arti fullname: Dell’Arti, L. organization: Moorfields Eye Hospital, Foundation IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Ophthalmological Unit – sequence: 4 givenname: J. surname: Guajardo fullname: Guajardo, J. organization: Moorfields Eye Hospital, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo – sequence: 5 givenname: S. surname: Leo fullname: Leo, S. organization: Moorfields Eye Hospital, University College London Institute of Ophthalmology – sequence: 6 givenname: A. G. surname: Robson fullname: Robson, A. G. organization: Moorfields Eye Hospital, University College London Institute of Ophthalmology – sequence: 7 givenname: S. A. surname: Trip fullname: Trip, S. A. organization: Queen Square MS CentreDepartment of Neuroinflammation, UCL Institute of Neurology – sequence: 8 givenname: A. surname: Petzold fullname: Petzold, A. organization: Moorfields Eye Hospital, Queen Square MS CentreDepartment of Neuroinflammation, UCL Institute of Neurology, Dutch Expertise Centre for Neuro-Ophthalmology and MS Centre, Departments of Neurology and Ophthalmology, Amsterdam UMC – sequence: 9 givenname: G. T. surname: Plant fullname: Plant, G. T. organization: Moorfields Eye Hospital, Queen Square MS CentreDepartment of Neuroinflammation, UCL Institute of Neurology – sequence: 10 givenname: G. E. surname: Holder fullname: Holder, G. E. organization: Moorfields Eye Hospital, University College London Institute of Ophthalmology, Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36161379$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kU9rFTEUxYNU7OvTL-BCAm7cjN4kM8lkKaVWoaCIrkMmc-eZMi955o_Qb2-eryp00VW45Hdyc865IGchBiTkJYO3DEC9ywykEB1w3oEetezkE7JhgxIdl5yfkQ0A413fj_KcXOR8CwBasfEZOReSSSaU3pDliy0FU6BXX68zzXW3w1yopYeYs59WpAmLD3alLoaS_FSLj4GWSMsPpL98ru3KuurLHV2bhPpwHAvSeCje0YA1-eLzc_J0sWvGF_fnlnz_cPXt8mN38_n60-X7m84JNZQOJaCW2qJ1g5RcCKbdNE5MDWIG1c9zzzTMC7dWjwiKz2Ieej4vo2ATQBu35M3p3UOKP2uzYvY-O1xXGzDWbHjzL0VbMTb09QP0NtbUrB4pMQxKDi3dLXl1T9Vpj7M5JL-36c78TbAB_AS41PwnXP4hDMyxJnOqybSazJ-ajGyi8YHI-WKP0ZZk_fq4VJykue0JO0z_v_2I6jfsTKZd |
| CitedBy_id | crossref_primary_10_1136_bmjopen_2023_076651 crossref_primary_10_1007_s00415_023_11709_y crossref_primary_10_1038_s41433_024_03154_6 crossref_primary_10_3390_biom15020158 crossref_primary_10_1167_tvst_13_2_18 |
| Cites_doi | 10.3390/ijms22073419 10.1371/journal.pone.0078341 10.1076/soph.18.2.50.15855 10.1177/2055217319871582 10.1023/A:1001844021014 10.1001/jama.1945.02860150014003 10.1016/S1474-4422(13)70259-X 10.1016/S1350-9462(00)00030-6 10.1038/nrneurol.2014.108 10.1007/s10633-016-9553-y 10.1002/ana.24006 10.1136/jnnp.52.12.1364 10.1038/eye.1997.231 10.1001/jamaneurol.2013.1832 10.1371/journal.pone.0071145 10.1016/j.ophtha.2013.08.045 10.1136/jnnp-2013-306902 10.1155/2020/4734276 10.1093/brain/awq346 10.1371/journal.pone.0034823 10.1038/sj.eye.6701573 10.1007/s10633-013-9401-2 10.1093/brain/109.3.469 10.1093/brain/awq080 10.1136/bjophthalmol-2014-305518 10.1093/brain/aww219 10.1016/S0140-6736(72)91155-5 10.1136/bjo.71.3.166 10.1016/0013-4694(91)90014-U 10.1093/brain/110.2.405 10.1016/j.clinph.2018.06.012 10.1007/BF00927252 |
| ContentType | Journal Article |
| Copyright | The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. |
| Copyright_xml | – notice: The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TK 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 |
| DOI | 10.1007/s10633-022-09896-6 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | ProQuest One Academic Middle East (New) MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1573-2622 |
| EndPage | 195 |
| ExternalDocumentID | 36161379 10_1007_s10633_022_09896_6 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: UCLH Biomedical Research Centre funderid: http://dx.doi.org/10.13039/501100012317 – fundername: National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology funderid: http://dx.doi.org/10.13039/501100012618 – fundername: European Committee for Treatment and Research in Multiple Sclerosis funderid: http://dx.doi.org/10.13039/100008659 |
| GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 199 1N0 1SB 2.D 203 28- 29G 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 3O- 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5VS 67Z 6NX 78A 7X7 88E 8AO 8FI 8FJ 8FW 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACNCT ACOKC ACOMO ACPIV ACPRK ACSNA ACUDM ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFFNX AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH L7B LAK LLZTM M1P M4Y MA- N2Q NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI ROL RPX RRX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 Z7U Z82 Z87 Z8O Z8V Z91 ZGI ZOVNA ZXP ~EX AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT PJZUB PPXIY PUEGO CGR CUY CVF ECM EIF NPM 7TK 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 |
| ID | FETCH-LOGICAL-c375t-e60e969aeac56623319cb8b1753d074dd4190df2aa98e072d3d542df831b002d3 |
| IEDL.DBID | BENPR |
| ISSN | 0012-4486 1573-2622 |
| IngestDate | Fri Sep 05 07:52:12 EDT 2025 Mon Oct 06 17:31:19 EDT 2025 Wed Feb 19 02:26:06 EST 2025 Thu Apr 24 23:07:24 EDT 2025 Wed Oct 01 02:18:56 EDT 2025 Fri Feb 21 02:44:26 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | Inner nuclear layer (INL) Multiple sclerosis Macular function Optic neuritis Optical coherence tomography (OCT) Pattern electroretinography (PERG) Pattern visual evoked potential (PVEP) |
| Language | English |
| License | 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c375t-e60e969aeac56623319cb8b1753d074dd4190df2aa98e072d3d542df831b002d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0001-6456-9034 |
| PMID | 36161379 |
| PQID | 2735576563 |
| PQPubID | 36417 |
| PageCount | 11 |
| ParticipantIDs | proquest_miscellaneous_2718639698 proquest_journals_2735576563 pubmed_primary_36161379 crossref_primary_10_1007_s10633_022_09896_6 crossref_citationtrail_10_1007_s10633_022_09896_6 springer_journals_10_1007_s10633_022_09896_6 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20221200 2022-12-00 20221201 |
| PublicationDateYYYYMMDD | 2022-12-01 |
| PublicationDate_xml | – month: 12 year: 2022 text: 20221200 |
| PublicationDecade | 2020 |
| PublicationPlace | Berlin/Heidelberg |
| PublicationPlace_xml | – name: Berlin/Heidelberg – name: Netherlands – name: Dordrecht |
| PublicationSubtitle | The Journal of Clinical Electrophysiology and Vision - The Official Journal of the International Society for Clinical Electrophysiology and Vision |
| PublicationTitle | Documenta ophthalmologica |
| PublicationTitleAbbrev | Doc Ophthalmol |
| PublicationTitleAlternate | Doc Ophthalmol |
| PublicationYear | 2022 |
| Publisher | Springer Berlin Heidelberg Springer Nature B.V |
| Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer Nature B.V |
| References | Al-NosairyKOHorbrüggerMSchipplingSStructure-function relationship of retinal ganglion cells in multiple sclerosisInt J Mol Sci20212211410.3390/ijms22073419 RuckerCSheathing of the retinal veins in multiple sclerosisJAMA194512797097310.1001/jama.1945.02860150014003 KaushikMWangCYBarnettMHInner nuclear layer thickening is inversley proportional to retinal ganglion cell loss in optic neuritisPLoS ONE2013841110.1371/journal.pone.00783411:CAS:528:DC%2BC3sXhsFyrurbJ KaufholdFZimmermannHSchneiderEOptic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosisPLoS ONE201310.1371/journal.pone.0071145239407063808533 KnierBSchmidtPAlyLRetinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosisBrain20161392855286310.1093/brain/aww21927581073 HokazonoKRazaASOyamadaMKPattern electroretinogram in neuromyelitis optica and multiple sclerosis with or without optic neuritis and its correlation with FD-OCT and perimetryDoc Ophthalmol201312720121510.1007/s10633-013-9401-223892551 HolderGEElectrophysiological assessment of optic nerve diseaseEye2004181133114310.1038/sj.eye.6701573155345991:STN:280:DC%2BD2crmtFOhsQ%3D%3D SaidhaSSycSSBIbrahimMMAPrimary retinal pathology in multiple sclerosis as detected by optical coherence tomographyBrain201113451853310.1093/brain/awq34621252110 AbeggMDysliMWolfSMicrocystic macular edema: retrograde maculopathy caused by optic neuropathyOphthalmology201412114214910.1016/j.ophtha.2013.08.04524139122 ViswanathanSFrishmanLJRobsonJGThe uniform field and pattern ERG in macaques with experimental glaucoma: removal of spiking activityInvestig Ophthalmol Vis Sci200041279728101:STN:280:DC%2BD3czps1agtw%3D%3D GelfandJMCreeBANolanRMicrocystic inner nuclear layer abnormalities and neuromyelitis opticaJAMA Neurol20137062963310.1001/jamaneurol.2013.183223529376 MessengerWHildebrandtLMackensenFCharacterisation of uveitis in association with multiple sclerosisBr J Ophthalmol20159920520910.1136/bjophthalmol-2014-30551825170065 HolderGEThe incidence of abnormal pattern electroretinography in optic nerve demyelinationElectroencephalogr Clin Neurophysiol199178182610.1016/0013-4694(91)90014-U17017101:STN:280:DyaK3M%2FnvVamsw%3D%3D HolderGEPattern electroretinography in patients with delayed pattern visual evoked potentials due to distal anterior visual pathway dysfunctionJ Neurol Neurosurg Psychiatry1989521364136810.1136/jnnp.52.12.1364261443110315931:STN:280:DyaK3c7jt1OhtA%3D%3D PlantGTHessRFThomasSJThe pattern evoked electroretinogram in optic neuritis: a combined psychophysical and electrophysiological studyBrain198610946948910.1093/brain/109.3.4693719286 Toosy AT, Mason DF, Miller DH (2014) Optic neuritis. Lancet Neurol 13:83–99. https://doi.org/10.1016/S1474-4422(13)70259-X MauguiereFHolderGLuxonLOsseltonJBinnieCCooperRAbnormal waveforms and diagnostic yield of evoked potentialsClinical neurophysiology: EMG; nerve conduction and evoked potentials1995OxfordButterworth-Heinemann431481 BerningerTAHeiderWPattern electroretinograms in optic neuritis during the acute stage and after remissionGraefe’s Arch Clin Exp Ophthalmol199022841041410.1007/BF009272521:STN:280:DyaK3M%2FjtlWjsg%3D%3D HallidayAMMcdonaldWIMushinJDelayed visual evoked response in optic neuritisLancet197229998298510.1016/S0140-6736(72)91155-5 WangMGuoHLiSElectrophysiological and structural changes in Chinese patients with LHONJ Ophthalmol202010.1155/2020/4734276337632377817228 Petzold A, Wattjes MP, Costello F et al (2014) The investigation of acute optic neuritis: a review and proposed protocol. Nat Rev Neurol 10:447–458. https://doi.org/10.1038/nrneurol.2014.108 BalkLJCoricDKnierBRetinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis; a longitudinal OCT studyMult Scler J Exp Transl Clin2019520552173198715810.1177/2055217319871582 TewariePBalkLCostelloFThe OSCAR-IB consensus criteria for retinal OCT quality assessmentPLoS ONE201271710.1371/journal.pone.00348231:CAS:528:DC%2BC38XmsFKjur4%3D HolderGEPattern electroretinography (PERG) and an integrated approach to visual pathway diagnosisProg Retin Eye Res20012053156110.1016/S1350-9462(00)00030-6113902581:STN:280:DC%2BD3MzitVKntQ%3D%3D OdomJVBachMBrigellMISCEV standard for clinical visual evoked potentials: (2016 update)Doc Ophthalmol201610.1007/s10633-016-9553-y28032236 HolderGVotrubaMCarterAElectrophysiological findings in dominant optic atrophy (DOA) linking to the OPA1 locus on chromosome 3q 28-qterDoc Ophthalmol19999521722810.1023/A:10018440210141:STN:280:DC%2BD3c%2FgtVajtA%3D%3D BalkLJTwiskJWRSteenwijkMDA dam for retrograde axonal degeneration in multiple sclerosis?J Neurol Neurosurg Psychiatry20148578278910.1136/jnnp-2013-306902244748221:STN:280:DC%2BC2czpvFWnsw%3D%3D ParisiVCorrelation between morphological and functional retinal impairment in patients affected by ocular hypertension, glaucoma, demyelinating optic neuritis and Alzheimer’s diseaseSemin Ophthalmol200318505710.1076/soph.18.2.50.1585514566623 DaviesALDesaiRABloomfieldPSNeurological deficits caused by tissue hypoxia in neuroinflammatory diseaseAnn Neurol20137481582510.1002/ana.24006240382791:CAS:528:DC%2BC2cXht1ehsbc%3D GreenAJMcQuaidSHauserSLOcular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease durationBrain20101331591160110.1093/brain/awq080204101462877904 LightmanSMcdonaldWIBirdACRetinal venous sheathing in optic neuritis: Its significance for the pathogenesis of multiple sclerosisBrain198711040541410.1093/brain/110.2.4053567529 HolderGESignificance of abnormal pattern electroretinography in anterior visual pathway dysfunctionBr J Ophthalmol19877116617110.1136/bjo.71.3.166382826910411121:STN:280:DyaL2s7lslGltg%3D%3D HolderGEThe pattern electroretinogram in anterior visual pathway dysfunction and its relationship to the pattern visual evoked potential: a personal clinical review of 743 eyesEye19971192493410.1038/eye.1997.2319537157 MonsalvePRenSJiangHRetinal ganglion cell function in recovered optic neuritis: faster is not betterClin Neurophysiol20181291813181810.1016/j.clinph.2018.06.01229981956 M Wang (9896_CR28) 2020 P Tewarie (9896_CR19) 2012; 7 GE Holder (9896_CR21) 2004; 18 9896_CR2 TA Berninger (9896_CR17) 1990; 228 LJ Balk (9896_CR32) 2014; 85 AM Halliday (9896_CR22) 1972; 299 V Parisi (9896_CR24) 2003; 18 M Kaushik (9896_CR10) 2013; 8 B Knier (9896_CR11) 2016; 139 JM Gelfand (9896_CR8) 2013; 70 GE Holder (9896_CR20) 1989; 52 W Messenger (9896_CR6) 2015; 99 AJ Green (9896_CR7) 2010; 133 S Viswanathan (9896_CR13) 2000; 41 GT Plant (9896_CR15) 1986; 109 GE Holder (9896_CR16) 2001; 20 LJ Balk (9896_CR4) 2019; 5 F Kaufhold (9896_CR3) 2013 C Rucker (9896_CR33) 1945; 127 K Hokazono (9896_CR23) 2013; 127 S Lightman (9896_CR5) 1987; 110 S Saidha (9896_CR31) 2011; 134 KO Al-Nosairy (9896_CR25) 2021; 22 AL Davies (9896_CR34) 2013; 74 G Holder (9896_CR29) 1999; 95 P Monsalve (9896_CR27) 2018; 129 GE Holder (9896_CR14) 1991; 78 JV Odom (9896_CR18) 2016 9896_CR1 M Abegg (9896_CR9) 2014; 121 GE Holder (9896_CR12) 1987; 71 F Mauguiere (9896_CR30) 1995 GE Holder (9896_CR26) 1997; 11 |
| References_xml | – reference: GelfandJMCreeBANolanRMicrocystic inner nuclear layer abnormalities and neuromyelitis opticaJAMA Neurol20137062963310.1001/jamaneurol.2013.183223529376 – reference: KaushikMWangCYBarnettMHInner nuclear layer thickening is inversley proportional to retinal ganglion cell loss in optic neuritisPLoS ONE2013841110.1371/journal.pone.00783411:CAS:528:DC%2BC3sXhsFyrurbJ – reference: SaidhaSSycSSBIbrahimMMAPrimary retinal pathology in multiple sclerosis as detected by optical coherence tomographyBrain201113451853310.1093/brain/awq34621252110 – reference: HolderGESignificance of abnormal pattern electroretinography in anterior visual pathway dysfunctionBr J Ophthalmol19877116617110.1136/bjo.71.3.166382826910411121:STN:280:DyaL2s7lslGltg%3D%3D – reference: KaufholdFZimmermannHSchneiderEOptic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosisPLoS ONE201310.1371/journal.pone.0071145239407063808533 – reference: TewariePBalkLCostelloFThe OSCAR-IB consensus criteria for retinal OCT quality assessmentPLoS ONE201271710.1371/journal.pone.00348231:CAS:528:DC%2BC38XmsFKjur4%3D – reference: ViswanathanSFrishmanLJRobsonJGThe uniform field and pattern ERG in macaques with experimental glaucoma: removal of spiking activityInvestig Ophthalmol Vis Sci200041279728101:STN:280:DC%2BD3czps1agtw%3D%3D – reference: HokazonoKRazaASOyamadaMKPattern electroretinogram in neuromyelitis optica and multiple sclerosis with or without optic neuritis and its correlation with FD-OCT and perimetryDoc Ophthalmol201312720121510.1007/s10633-013-9401-223892551 – reference: HolderGVotrubaMCarterAElectrophysiological findings in dominant optic atrophy (DOA) linking to the OPA1 locus on chromosome 3q 28-qterDoc Ophthalmol19999521722810.1023/A:10018440210141:STN:280:DC%2BD3c%2FgtVajtA%3D%3D – reference: BerningerTAHeiderWPattern electroretinograms in optic neuritis during the acute stage and after remissionGraefe’s Arch Clin Exp Ophthalmol199022841041410.1007/BF009272521:STN:280:DyaK3M%2FjtlWjsg%3D%3D – reference: MauguiereFHolderGLuxonLOsseltonJBinnieCCooperRAbnormal waveforms and diagnostic yield of evoked potentialsClinical neurophysiology: EMG; nerve conduction and evoked potentials1995OxfordButterworth-Heinemann431481 – reference: RuckerCSheathing of the retinal veins in multiple sclerosisJAMA194512797097310.1001/jama.1945.02860150014003 – reference: Al-NosairyKOHorbrüggerMSchipplingSStructure-function relationship of retinal ganglion cells in multiple sclerosisInt J Mol Sci20212211410.3390/ijms22073419 – reference: HolderGEThe incidence of abnormal pattern electroretinography in optic nerve demyelinationElectroencephalogr Clin Neurophysiol199178182610.1016/0013-4694(91)90014-U17017101:STN:280:DyaK3M%2FnvVamsw%3D%3D – reference: KnierBSchmidtPAlyLRetinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosisBrain20161392855286310.1093/brain/aww21927581073 – reference: HolderGEThe pattern electroretinogram in anterior visual pathway dysfunction and its relationship to the pattern visual evoked potential: a personal clinical review of 743 eyesEye19971192493410.1038/eye.1997.2319537157 – reference: BalkLJTwiskJWRSteenwijkMDA dam for retrograde axonal degeneration in multiple sclerosis?J Neurol Neurosurg Psychiatry20148578278910.1136/jnnp-2013-306902244748221:STN:280:DC%2BC2czpvFWnsw%3D%3D – reference: DaviesALDesaiRABloomfieldPSNeurological deficits caused by tissue hypoxia in neuroinflammatory diseaseAnn Neurol20137481582510.1002/ana.24006240382791:CAS:528:DC%2BC2cXht1ehsbc%3D – reference: PlantGTHessRFThomasSJThe pattern evoked electroretinogram in optic neuritis: a combined psychophysical and electrophysiological studyBrain198610946948910.1093/brain/109.3.4693719286 – reference: WangMGuoHLiSElectrophysiological and structural changes in Chinese patients with LHONJ Ophthalmol202010.1155/2020/4734276337632377817228 – reference: GreenAJMcQuaidSHauserSLOcular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease durationBrain20101331591160110.1093/brain/awq080204101462877904 – reference: HolderGEElectrophysiological assessment of optic nerve diseaseEye2004181133114310.1038/sj.eye.6701573155345991:STN:280:DC%2BD2crmtFOhsQ%3D%3D – reference: Petzold A, Wattjes MP, Costello F et al (2014) The investigation of acute optic neuritis: a review and proposed protocol. Nat Rev Neurol 10:447–458. https://doi.org/10.1038/nrneurol.2014.108 – reference: MessengerWHildebrandtLMackensenFCharacterisation of uveitis in association with multiple sclerosisBr J Ophthalmol20159920520910.1136/bjophthalmol-2014-30551825170065 – reference: AbeggMDysliMWolfSMicrocystic macular edema: retrograde maculopathy caused by optic neuropathyOphthalmology201412114214910.1016/j.ophtha.2013.08.04524139122 – reference: MonsalvePRenSJiangHRetinal ganglion cell function in recovered optic neuritis: faster is not betterClin Neurophysiol20181291813181810.1016/j.clinph.2018.06.01229981956 – reference: HolderGEPattern electroretinography (PERG) and an integrated approach to visual pathway diagnosisProg Retin Eye Res20012053156110.1016/S1350-9462(00)00030-6113902581:STN:280:DC%2BD3MzitVKntQ%3D%3D – reference: Toosy AT, Mason DF, Miller DH (2014) Optic neuritis. Lancet Neurol 13:83–99. https://doi.org/10.1016/S1474-4422(13)70259-X – reference: HolderGEPattern electroretinography in patients with delayed pattern visual evoked potentials due to distal anterior visual pathway dysfunctionJ Neurol Neurosurg Psychiatry1989521364136810.1136/jnnp.52.12.1364261443110315931:STN:280:DyaK3c7jt1OhtA%3D%3D – reference: ParisiVCorrelation between morphological and functional retinal impairment in patients affected by ocular hypertension, glaucoma, demyelinating optic neuritis and Alzheimer’s diseaseSemin Ophthalmol200318505710.1076/soph.18.2.50.1585514566623 – reference: LightmanSMcdonaldWIBirdACRetinal venous sheathing in optic neuritis: Its significance for the pathogenesis of multiple sclerosisBrain198711040541410.1093/brain/110.2.4053567529 – reference: BalkLJCoricDKnierBRetinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis; a longitudinal OCT studyMult Scler J Exp Transl Clin2019520552173198715810.1177/2055217319871582 – reference: OdomJVBachMBrigellMISCEV standard for clinical visual evoked potentials: (2016 update)Doc Ophthalmol201610.1007/s10633-016-9553-y28032236 – reference: HallidayAMMcdonaldWIMushinJDelayed visual evoked response in optic neuritisLancet197229998298510.1016/S0140-6736(72)91155-5 – volume: 22 start-page: 1 year: 2021 ident: 9896_CR25 publication-title: Int J Mol Sci doi: 10.3390/ijms22073419 – volume: 8 start-page: 4 year: 2013 ident: 9896_CR10 publication-title: PLoS ONE doi: 10.1371/journal.pone.0078341 – volume: 18 start-page: 50 year: 2003 ident: 9896_CR24 publication-title: Semin Ophthalmol doi: 10.1076/soph.18.2.50.15855 – volume: 5 start-page: 205521731987158 year: 2019 ident: 9896_CR4 publication-title: Mult Scler J Exp Transl Clin doi: 10.1177/2055217319871582 – volume: 95 start-page: 217 year: 1999 ident: 9896_CR29 publication-title: Doc Ophthalmol doi: 10.1023/A:1001844021014 – volume: 127 start-page: 970 year: 1945 ident: 9896_CR33 publication-title: JAMA doi: 10.1001/jama.1945.02860150014003 – ident: 9896_CR2 doi: 10.1016/S1474-4422(13)70259-X – volume: 20 start-page: 531 year: 2001 ident: 9896_CR16 publication-title: Prog Retin Eye Res doi: 10.1016/S1350-9462(00)00030-6 – ident: 9896_CR1 doi: 10.1038/nrneurol.2014.108 – year: 2016 ident: 9896_CR18 publication-title: Doc Ophthalmol doi: 10.1007/s10633-016-9553-y – volume: 74 start-page: 815 year: 2013 ident: 9896_CR34 publication-title: Ann Neurol doi: 10.1002/ana.24006 – volume: 52 start-page: 1364 year: 1989 ident: 9896_CR20 publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.52.12.1364 – volume: 11 start-page: 924 year: 1997 ident: 9896_CR26 publication-title: Eye doi: 10.1038/eye.1997.231 – volume: 70 start-page: 629 year: 2013 ident: 9896_CR8 publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2013.1832 – year: 2013 ident: 9896_CR3 publication-title: PLoS ONE doi: 10.1371/journal.pone.0071145 – volume: 121 start-page: 142 year: 2014 ident: 9896_CR9 publication-title: Ophthalmology doi: 10.1016/j.ophtha.2013.08.045 – volume: 85 start-page: 782 year: 2014 ident: 9896_CR32 publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2013-306902 – year: 2020 ident: 9896_CR28 publication-title: J Ophthalmol doi: 10.1155/2020/4734276 – volume: 134 start-page: 518 year: 2011 ident: 9896_CR31 publication-title: Brain doi: 10.1093/brain/awq346 – volume: 7 start-page: 1 year: 2012 ident: 9896_CR19 publication-title: PLoS ONE doi: 10.1371/journal.pone.0034823 – volume: 18 start-page: 1133 year: 2004 ident: 9896_CR21 publication-title: Eye doi: 10.1038/sj.eye.6701573 – volume: 127 start-page: 201 year: 2013 ident: 9896_CR23 publication-title: Doc Ophthalmol doi: 10.1007/s10633-013-9401-2 – volume: 109 start-page: 469 year: 1986 ident: 9896_CR15 publication-title: Brain doi: 10.1093/brain/109.3.469 – volume: 133 start-page: 1591 year: 2010 ident: 9896_CR7 publication-title: Brain doi: 10.1093/brain/awq080 – volume: 99 start-page: 205 year: 2015 ident: 9896_CR6 publication-title: Br J Ophthalmol doi: 10.1136/bjophthalmol-2014-305518 – volume: 139 start-page: 2855 year: 2016 ident: 9896_CR11 publication-title: Brain doi: 10.1093/brain/aww219 – volume: 299 start-page: 982 year: 1972 ident: 9896_CR22 publication-title: Lancet doi: 10.1016/S0140-6736(72)91155-5 – volume: 71 start-page: 166 year: 1987 ident: 9896_CR12 publication-title: Br J Ophthalmol doi: 10.1136/bjo.71.3.166 – volume: 78 start-page: 18 year: 1991 ident: 9896_CR14 publication-title: Electroencephalogr Clin Neurophysiol doi: 10.1016/0013-4694(91)90014-U – volume: 110 start-page: 405 year: 1987 ident: 9896_CR5 publication-title: Brain doi: 10.1093/brain/110.2.405 – start-page: 431 volume-title: Clinical neurophysiology: EMG; nerve conduction and evoked potentials year: 1995 ident: 9896_CR30 – volume: 129 start-page: 1813 year: 2018 ident: 9896_CR27 publication-title: Clin Neurophysiol doi: 10.1016/j.clinph.2018.06.012 – volume: 41 start-page: 2797 year: 2000 ident: 9896_CR13 publication-title: Investig Ophthalmol Vis Sci – volume: 228 start-page: 410 year: 1990 ident: 9896_CR17 publication-title: Graefe’s Arch Clin Exp Ophthalmol doi: 10.1007/BF00927252 |
| SSID | ssj0009718 |
| Score | 2.3385847 |
| Snippet | Purpose
Macular involvement in optic neuritis (ON) is well-recognised but poorly understood and may be of clinical relevance. This study explores macular... Macular involvement in optic neuritis (ON) is well-recognised but poorly understood and may be of clinical relevance. This study explores macular... PurposeMacular involvement in optic neuritis (ON) is well-recognised but poorly understood and may be of clinical relevance. This study explores macular... |
| SourceID | proquest pubmed crossref springer |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 185 |
| SubjectTerms | Acuity Antibodies Cross-Sectional Studies Electrodes Electroretinography - methods Evoked Potentials, Visual Eye Glycoproteins Humans Inflammatory diseases Medicine Medicine & Public Health Multiple sclerosis Myelin Neuritis Neurology Oligodendrocyte-myelin glycoprotein Ophthalmology Optic nerve Optic neuritis Optic Neuritis - diagnosis Optics Original Research Article Patients Structure-function relationships Tomography Tomography, Optical Coherence - methods Vision Disorders Visual Acuity Visual evoked potentials |
| SummonAdditionalLinks | – databaseName: SpringerLink Journals (ICM) dbid: U2A link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fS8MwEA46QXwRfzudEsE3LbRJmzaPQzaHMBFxsLeSNqkIox229e_3rks3ZSrYt5JcWi6Xyxfu7gsh1yrFIxc3jhGaO2AUxokYTzCZCh7Pk5nG2uHxoxhN_IdpMLVFYWWb7d6GJBtP_aXYTXCMOTLHlZEUjtgkWwHSeYEVT1h_RbUbetb_MgcOH8KWyvw8xvftaA1jrsVHm21nuEd2LV6k_cUE75MNkx-Q7bGNiB-S7KkhyMzp4Pm-pGX9ivEiqui8QGOfGYpVijhCk5NuL7eiVUEB-NGPt7KGJpXWgMXpDEToW46vlaEF-JKUIt0lsh4dkclw8HI3cuzdCU7Kw6AC1btGCqnArwJgYxxWWppECfJyakANWvuABHTGlJKRcUOmuQ58prOIe7hva35MOnmRm1NCjUjdNPNB3gR-kuiIZa4JXc8oCVgvEV3itSqMU0ssjvdbzOIVJTKqPQa1x43aY5C5WcrMF7Qaf_butTMT2yVWxoC7AjgsBYJ3ydWyGRYHRjxUbooa-3gRQDAhoy45Wczo8nNcANjloeyS23aKV4P__i9n_-t-TnYYmluTANMjneq9NhcAY6rksrHaTy3R5zs priority: 102 providerName: Springer Nature |
| Title | Pattern ERGs suggest a possible retinal contribution to the visual acuity loss in acute optic neuritis |
| URI | https://link.springer.com/article/10.1007/s10633-022-09896-6 https://www.ncbi.nlm.nih.gov/pubmed/36161379 https://www.proquest.com/docview/2735576563 https://www.proquest.com/docview/2718639698 |
| Volume | 145 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVLSH databaseName: SpringerLink Journals customDbUrl: mediaType: online eissn: 1573-2622 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0009718 issn: 0012-4486 databaseCode: AFBBN dateStart: 19970301 isFulltext: true providerName: Library Specific Holdings – providerCode: PRVPQU databaseName: Health & Medical Collection (ProQuest) customDbUrl: eissn: 1573-2622 dateEnd: 20241028 omitProxy: true ssIdentifier: ssj0009718 issn: 0012-4486 databaseCode: 7X7 dateStart: 19970301 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1573-2622 dateEnd: 20241028 omitProxy: true ssIdentifier: ssj0009718 issn: 0012-4486 databaseCode: BENPR dateStart: 19970301 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK - Czech Republic Consortium customDbUrl: eissn: 1573-2622 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0009718 issn: 0012-4486 databaseCode: AGYKE dateStart: 19970101 isFulltext: true titleUrlDefault: http://link.springer.com providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 1573-2622 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0009718 issn: 0012-4486 databaseCode: U2A dateStart: 19970101 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fa9swED7aBMZexn4vXRc02NsmZku2bD2MkY20ZaOhlAWyJyNL8igEO2vs_f27c-SEUVa_2ZJsoZNOn3x33wG8M5aOXNJzr5zkOCk8z4UsyZkKrzjWlaPY4cuFulgm31bp6ggWQywMuVUOOrFX1K6x9I_8I26zKWLjVMnPm9-cskaRdXVIoWFCagX3qacYO4axIGasEYy_zBdX1wca3iwOullwPJioEEYTgumUJJum4JHOteLq363qDv68Yzvtt6Szx_AoYEk22wn_CRz5-ik8uAzW8mdQXfXkmTWbX59v2bb7RbYkZtimoYWw9owiGOkNvb96SHzF2oYhKGR_brYdFhnbIU5na2zCbmq6bT1rUM9YRlSYxIj0HJZn8x9fL3jIq8CtzNIWxRJ5rbRBnYtgTkhchbbMS-LsdIgonEsQJbhKGKNzH2XCSZcmwlW5jGlPd_IFjOqm9q-AeWUjWyXY3qdJWbpcVJHPotgbjTiwVBOIhyEsbCAdp9wX6-JAl0zDXuCwF_2wF9jm_b7NZke5cW_t00EyRVh-2-IwWSbwdl-MC4esIab2TUd14hzhmdL5BF7uJLr_nFQIhGWmJ_BhEPHh5f_vy8n9fXkNDwVNr94Z5hRG7W3n3yCkacspHGerbArj2fnP7_NpmLX4dClmfwELafQ1 |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VVgIuiDcLBYwEJ4hI7MSJDxXisWVLu6uqaqXegmM7qNIq2TYJiD_Hb2Mm6-wKVfTW3KLEjjUee77JeL4BeK0NuVzCBU5aEaBSuCDjoqDDVHhFkSot5Q5PZ3JyEn87TU434M-QC0PHKoc9sd-obW3oH_l7NLMJYuNEig-L84CqRlF0dSihoX1pBbvTU4z5xI599_sXunDNzt4XnO83nO-Ojz9PAl9lIDAiTVocZOiUVBp3IIQ2XKBOmiIriMHSon21NkabaUuutcpcmHIrbBJzW2YiIgtnBfZ7A7ZiESt0_rY-jWeHR2va3zTytoAH6AhJn7bjk_ekoBgqD0KVKRnIf03jJbx7KVbbm8Ddu3DHY1f2cals92DDVffh5tRH5x9AediTdVZsfPS1YU33g2JXTLNFTQtv7hhlTFIP_fl4X2iLtTVDEMp-njUdPtKmQ7-AzbEJO6votnWsxn3NMKLeJAamh3ByLRJ-BJtVXbknwJw0oSljbO-SuChsxsvQpWHktELcWcgRRIMIc-NJzqnWxjxf0zOT2HMUe96LPcc2b1dtFkuKjyvf3h5mJvfLvcnXyjmCV6vHuFAp-qIrV3f0TpQhHJQqG8Hj5YyuPickAm-RqhG8G6Z43fn_x_L06rG8hFuT4-lBfrA3238GtzmpWn8QZxs224vOPUc41RYvvM4y-H7dy-QvAxEtLg |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VVqq4ICivhVKMVE5gNbETJz4ghNoufdCqQlTaW0hsB1VaJdsmAfWv9dcxk3V2hSp6a26RH7HGM57PmRfAdm7oyiUdd8pKjkzheCpkQc5U-IShLi3FDp-cqoPz6GgST1bgZoiFIbfK4UzsD2pbG_pHvoNqNkZsHCu5U3q3iLO98efZJacKUmRpHcppzFnk2F3_wetb8-lwD_f6vRDj_R-7B9xXGOBGJnGLCwycVjrH0wdhjZDIj6ZIC8peaVG3WhuhvrSlyHOduiARVto4ErZMZUjazUqc9wGsJVJqcidMJsky4W8Sei0gOF6BlA_Y8WF7SpL1VPBAp1px9a9SvIV0b1lpe-U3fgyPPGplX-Zs9gRWXLUB6yfeLv8UyrM-TWfF9r9_bVjT_SKrFcvZrCaRmzpGsZI0Q-8Z70tssbZmCD_Z74umw6bcdHgjYFMcwi4qem0dq_FEM4ySblLupWdwfi_0fQ6rVV25l8CcMoEpIxzv4qgobCrKwCVB6HKNiLNQIwgHEmbGpzenKhvTbJmYmcieIdmznuwZjvmwGDObJ_e4s_fmsDOZF_QmW7LlCN4tmlFEye6SV67uqE-YIhBUOh3Bi_mOLj4nFUJumegRfBy2eDn5_9fy6u61vIV1FI7s2-Hp8Wt4KIjTeg-cTVhtrzr3BnFUW2z1DMvg531LyF-xpirI |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pattern+ERGs+suggest+a+possible+retinal+contribution+to+the+visual+acuity+loss+in+acute+optic+neuritis&rft.jtitle=Documenta+ophthalmologica&rft.au=Kleerekooper%2C+I.&rft.au=Del+Porto%2C+L.&rft.au=Dell%E2%80%99Arti%2C+L.&rft.au=Guajardo%2C+J.&rft.date=2022-12-01&rft.issn=0012-4486&rft.eissn=1573-2622&rft.volume=145&rft.issue=3&rft.spage=185&rft.epage=195&rft_id=info:doi/10.1007%2Fs10633-022-09896-6&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s10633_022_09896_6 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-4486&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-4486&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-4486&client=summon |